Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Science Année : 2010

Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats

Věra Čertíková Chábová
  • Fonction : Auteur
Agnieszka Walkowska
  • Fonction : Auteur
Elzbieta Kompanowska-Jezierska
  • Fonction : Auteur
Janusz Sadowski
  • Fonction : Auteur
Peter Kujal
  • Fonction : Auteur
Zdena Vernerová
  • Fonction : Auteur
Zdenka Vaňourková
  • Fonction : Auteur
Libor Kopkan
  • Fonction : Auteur
Herbert J Kramer
  • Fonction : Auteur
John R Falck
  • Fonction : Auteur
John D Imig
  • Fonction : Auteur
Bruce D Hammock
  • Fonction : Auteur
Ivana Vaněčková
  • Fonction : Auteur

Résumé

Recent studies have shown that the renal cytochrome P-450 metabolites of arachidonic acid: the vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE), and the vasodilator epoxyeicosatrienoic acids (EETs) play an important role in the pathophysiology of angiotensin II (ANG II)-dependent forms of hypertension and the associated target organ damage. The present studies were performed in Ren-2 renin transgenic rats (TGR) to evaluate the effects of chronic selective inhibition of 20-HETE formation or elevation of the level of EETs, alone or in combination, on the course of hypertension and hypertension-associated end-organ damage. Both young (30 days of age) prehypertensive TGR and adult (190 days of age) TGR with established hypertension were examined. Normotensive Hannover Sprague-Dawley (HanSD) rats served as controls. The rats were treated with N-methylsulfonyl-12,12-dibromododec-11-enamide to inhibit 20-HETE formation and/or with N-cyclohexyl-N-dodecyl urea to inhibit soluble epoxide hydrolase and prevent degradation of EETs. Inhibition in TGR rats of 20-HETE formation combined with enhanced bioavailability of EETs attenuated the development of hypertension, cardiac hypertrophy, proteinuria, glomerular hypertrophy and sclerosis as well as renal tubulointerstitial injury . This was also associated with an attenuation of the responsiveness of the systemic and renal vascular beds to ANG II without modifying their responses to norepinephrine. Our data suggest that altered production and/or action of 20-HETE and EETs plays a permissive role in the development of hypertension and hypertension-associated end-organ damage in this model of ANG II-dependent hypertension. This information provides a basis for a search of new therapeutic approaches to the treatment of hypertension.

Mots clés

Fichier principal
Vignette du fichier
PEER_stage2_10.1042%2FCS20090459.pdf (3.7 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00568405 , version 1 (23-02-2011)

Identifiants

Citer

Věra Čertíková Chábová, Agnieszka Walkowska, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, Peter Kujal, et al.. Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats. Clinical Science, 2010, 118 (10), pp.617-632. ⟨10.1042/CS20090459⟩. ⟨hal-00568405⟩

Collections

PEER
137 Consultations
271 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More